𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMA

✍ Scribed by MAILLEFERT, J.F.; SIBILIA, J.; MICHEL, F.; SAUSSINE, C.; JAVIER, R.M.; TAVERNIER, C.

Book ID
122263221
Publisher
Lippincott Williams and Wilkins
Year
1999
Tongue
English
Weight
405 KB
Volume
161
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Changes in bone mineral density and body
Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma
✍ Hang Lee; Katelyn McGovern; Joel S. Finkelstein; Matthew R. Smith πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Initial treatment with a gonadotropin‐releasing hormone (GnRH) agonist increases fat mass, decreases lean body mass, and decreases bone mineral density (BMD) in men with prostate carcinoma. To the authors' knowledge, little is known regarding either the long‐term effects